CHART OF THE DAY

Chart of the Day: OZEM ETF hoping there is still fuel in the megatrend second only to AI

The OZEM ETF hopes to bank on the mega success of the miraculous weight loss drug, and the list of holdings should be fertile ground for stock pickers looking for a more direct ride on the wave.

Johan Widmark

May 28, 2024 — 1 min read

Roundhill Investments' GLP-1 & Weight Loss ETF (OZEM), which launched last week, features industry leaders Eli Lilly and Novo Nordisk alongside emerging players in weight loss and diabetes treatment development. CEO Dave Mazza said to CNBC the ETF is tapping into the sector's explosive growth potential. Eli Lilly and Novo Nordisk each make up about 21% of the ETF, while the next three largest holdings—Zealand Pharma, Amgen, and Chugai Pharmaceutical—each have a weighting of less than 5%.

Although it has only been a few days of trading, it's no immediate success so far.

However, if the success of Ozempic continues, the companies further down the list of the ETF's 30 holdings should be a good place to start looking for second and third-order beneficiaries.

OZEM ETF (black), S&P500 Index (green). **Source:** TradingVIew

New weight-loss drug ETF — **Source:** Bloomberg Intelligence

Model Portfolio up 28% (vs SPX 17%) on strong $RDDT and Silver - now adding SK Hynix on surging HBM chip demand

Model Portfolio now up 28% vs SPX at 17%. Adding SK Hynix as HBM chips are next in line to benefit from AI's explosive growth. With a strong market lead and high margins, SK Hynix is positioned for growth.

Basket of biotechs most likely to benefit from advances in AI in 2025

While AI has driven rapid gains in semiconductors, its impact on the real economy is lagging, especially in biotech. Here, we present an equal-weighted basket of seven biotechs, up 38% in the past year, including Alnylam and Sarepta, expected to benefit from AI in 2025.

Record optimism in tech as positive EPS guidance surges to three-year high in Q3 2024

In Q3 2024, S&P 500 companies showed a shift in earnings outlook, with 110 issuing EPS guidance: 60 gave negative guidance, while 50 offered positive, according to FactSet.

Ever wonder how hackers get malware onto your computer? Here’s the modus that tricks even the most tech savvy

Are you like me, thinking you're too clever and alert to fall for advanced hacking schemes? Think again. Here’s how hackers use sophisticated tactics to slip malware past even the most cautious users—and what you can do to stay safe.

Read more

Model Portfolio up 28% (vs SPX 17%) on strong $RDDT and Silver - now adding SK Hynix on surging HBM chip demand

Basket of biotechs most likely to benefit from advances in AI in 2025

Record optimism in tech as positive EPS guidance surges to three-year high in Q3 2024

Ever wonder how hackers get malware onto your computer? Here’s the modus that tricks even the most tech savvy